Literature DB >> 28318837

Innovations in first episode psychosis interventions: The case for a "RAISE-Plus" approach.

Emily Kline1, Matcheri Keshavan2.   

Abstract

Several papers in the current issue of Schizophrenia Research show evidence supporting interventions that are not yet grouped with standard care practices in FEP. Taken together, these studies make the case for a more inclusive approach for early psychosis care than what is embodied in RAISE. Although providing all interventions to all patients, however, will be impractical and expensive, a personalized approach to such interventions, whereby the appropriate interventions are implemented in a phase specific and individually tailored manner after a careful assessment of each person's core deficits within a coordinated specialty care model, is likely to improve lives and be cost-effective.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Early intervention; Evidence based treatment

Mesh:

Year:  2017        PMID: 28318837     DOI: 10.1016/j.schres.2017.03.035

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  3 in total

Review 1.  The History of Coordinated Specialty Care for Early Intervention in Psychosis in the United States: A Review of Effectiveness, Implementation, and Fidelity.

Authors:  Halley Read; Brandon A Kohrt
Journal:  Community Ment Health J       Date:  2021-09-14

2.  Affective Dysregulation Precedes Emergence of Psychosis-Like Experiences in a Community Sample of Young Adults.

Authors:  Lindsay A Bornheimer; Meghan E Martz; Takakuni Suzuki; Ivy F Tso; Cynthia Z Burton; Juliann Li Verdugo; Tyler Grove; Mary M Heitzeg; Stephan F Taylor
Journal:  Schizophr Bull       Date:  2022-05-07       Impact factor: 7.348

3.  Cost Utility of cognition-enhancing interventions for individuals with first-episode psychosis: a naturalistic evaluation.

Authors:  Nicholas J K Breitborde; Emily K Bell; Cindy Woolverton; Jacob G Pine; Heather Waslter; Aubrey M Moe
Journal:  Cost Eff Resour Alloc       Date:  2021-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.